Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Simple item page
dc.contributor.authorFinn, R.S.
dc.contributor.authorRyoo, B.Y.
dc.contributor.authorMerle, P.
dc.contributor.authorBouattour, M.
dc.contributor.authorLim, H.Y.
dc.contributor.authorBreder, V.
dc.contributor.authorEdeline, J.
dc.contributor.authorChao, Y.
dc.contributor.authorOgasawara, S.
dc.contributor.authorYau, T.
dc.contributor.authorGarrido, M.
dc.contributor.authorChan, S.L.
dc.contributor.authorKnox, J.
dc.contributor.authorDaniele, B.
dc.contributor.authorEbbinghaus, S.W.
dc.contributor.authorChen, E.
dc.contributor.authorSiegel, A.B.
dc.contributor.authorZhu, A.X.
dc.contributor.authorCheng, A.L.
dc.date.accessioned2020-05-19T20:43:01Z
dc.date.available2020-05-19T20:43:01Z
dc.date.issued2020
dc.fuente.origenConveris
dc.identifier.doi10.1200/JCO.19.01307
dc.identifier.issn0732-183X
dc.identifier.urihttps://doi.org/10.1200/JCO.19.01307
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/29032
dc.identifier.wosidWOS:000508197300004
dc.issue.numeroNo. 3
dc.language.isoen
dc.nota.accesocontenido completo
dc.pagina.final202
dc.pagina.inicio193
dc.revistaJournal of Clinical Oncologyes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.subject.otherCarcinoma hepatocelulares_ES
dc.subject.otherInmunoterapiaes_ES
dc.subject.otherFarmacologíaes_ES
dc.subject.otherSeguridad de productoses_ES
dc.titlePembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Triales_ES
dc.typeartículo
dc.volumenVol. 38
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Pembrolizumab As Second-Line Therapy in Patients.pdf
Size:
840.74 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas